Private Securities Litigation Reform Act of If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. View source version on businesswire.
Unsubscribe from email alerts. We are committed to providing leading innovations for today and the future that save and improve lives around the world. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. No Duty to Update The information contained in this website was current as of the date presented.
The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
By continuing, you will be directed to a site intended only for residents of the United States and Canada. Search for:. Sign up for email alerts. Related links. Organon was accused of selling its anti-depression medication Remeron at a discount to nursing home pharmacies in order to encourage use , yet filing claims to Medicare for reimbursement at the full, undiscounted price.
From Wikipedia, the free encyclopedia. Pharmaceutical company. Traded as. Jersey City, New Jersey , U. Science Museum Group. Retrieved 4 June Seeking Alpha. Archived from the original on 9 December Retrieved 19 June Archived from the original on 9 March Medical Net News.
American Enterprise Institute. Archived from the original PDF on 9 July Retrieved 21 February November 3, Archived from the original on November 7, Retrieved Retrieved 17 February Pharmaceutical companies of the United States.
Merck announced the spin-off earlier this year February The company says it is on track for completion of the spin-off in the first half of How to resolve AdBlock issue? Returning to Rahway as new global headquarters The move to consolidate its headquarter operations in Rahway is part of an overall restructuring initiative that the company had announced in Most Popular Articles. As a premier research-intensive biopharmaceutical company, Merck will continue its pursuit to advance the prevention and treatment of diseases that threaten people and communities around the world.
Carrie serves as chairman of the Organon Board of Directors. She is the former executive chairman of Humacyte, Inc. She joined Humacyte in as its CEO, adding the title of chairman in Carrie is a graduate of the Massachusetts College of Pharmacy. Kevin serves as our chief executive officer and is a member of the Board of Directors. Prior to this role, between and , Kevin was the president of MSD International, with commercial responsibility for all markets outside of the United States.
Earlier in his Merck career, Kevin was the president of the Emerging Markets region, where he transformed the performance of many markets into sustained growth and strength and introduced a number of important commercial development partnerships. He has also held several additional leadership roles at Merck, including senior vice president and general manager of the bone, respiratory, immunology and dermatology franchise; senior vice president and managing director of MSD in Germany; and managing director of MSD in Turkey.
He also serves as an executive in residence and adjunct professor of business at Columbia Business School. He was previously a senior vice president at Merck Research Laboratories responsible for the bone, respiratory, immunology, inflammation and dermatology franchises. In addition to her public health experience, Helene has significant public company governance experience.
She currently serves as a director on the boards of The Coca-Cola Company, where she chairs the human capital management and compensation committee; the Colgate-Palmolive Company, where she chairs the nominating, governance and corporate responsibility committee; as well as GoHealth, Inc. Helene earned a B. She previously served on the Board of Directors of Merck from to and the General Electric Company from to She is currently a director of the Blackstone Group.
Shelly is also a trustee of the New York Presbyterian Hospital and is a member of the Board of Overseers of Columbia Business School as well as several other charitable and civic organizations. Debbie is the former chief operating officer, investment management at the Goldman Sachs Group, Inc. Prior to her COO role, she served as a partner and director of internal audit at Goldman Sachs from to , and as partner and controller, investment management from to Debbie received a B.
Her practice focuses on mergers and acquisitions, corporate governance and private equity. She received a law degree from Fordham University and a B. Prior to joining Montefiore, Philip was chairman and professor of the department of pediatrics and the department of epidemiology, population health at the Albert Einstein College of Medicine. Originally from Nigeria, he earned a medical degree from the University of Ibadan. He also holds a Ph. Cynthia is currently executive vice president and general counsel at Verily Life Sciences, part of Alphabet Inc.
Previously, she served as senior vice president and chief compliance officer at Amgen Inc. She received a J. Grace serves as executive vice president, global operations at PepsiCo, Inc. Over a career spanning multiple industries, Grace has served as senior vice president and global chief procurement officer at PepsiCo to , senior vice president and global chief procurement officer at United Continental Holdings and in positions of increasing responsibility at Kraft Foods, Inc.
She served as a director of Williams-Sonoma, Inc. Shalini has extensive public company governance experience in the biotechnology industry, having served as a director and chair of the audit committee at Sutro Biopharma, Inc. She also currently serves as a director at Neurocrine Biosciences, Inc.